These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36134203)

  • 21. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle-Mediated Dual Targeting: An Approach for Enhanced Baicalin Delivery to the Liver.
    Ahmed IS; Rashed HM; Fayez H; Farouk F; Shamma RN
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 32013203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
    Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier.
    Park IK; Park YH; Shin BA; Choi ES; Kim YR; Akaike T; Cho CS
    J Control Release; 2000 Oct; 69(1):97-108. PubMed ID: 11018549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.
    Deng G; Ma C; Zhao H; Zhang S; Liu J; Liu F; Chen Z; Chen AT; Yang X; Avery J; Zou P; Du F; Lim KP; Holden D; Li S; Carson RE; Huang Y; Chen Q; Kimberly WT; Simard JM; Sheth KN; Zhou J
    Theranostics; 2019; 9(23):6991-7002. PubMed ID: 31660082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy
    Xiang Y; Huang W; Huang C; Long J; Zhou Y; Liu Y; Tang S; He DX; Tan XW; Wei H; Yu CY
    Mol Pharm; 2020 Sep; 17(9):3223-3235. PubMed ID: 32658485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
    AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-fibrotic effect of betulinic acid is mediated through the inhibition of NF-κB nuclear protein translocation.
    Wan Y; Wu YL; Lian LH; Xie WX; Li X; Ouyang BQ; Bai T; Li Q; Yang N; Nan JX
    Chem Biol Interact; 2012 Feb; 195(3):215-23. PubMed ID: 22285267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
    Kim EM; Jeong HJ; Park IK; Cho CS; Kim CG; Bom HS
    J Nucl Med; 2005 Jan; 46(1):141-5. PubMed ID: 15632044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization and Characterization of Low-Molecular-Weight Chitosan-Coated Baicalin mPEG-PLGA Nanoparticles for the Treatment of Cataract.
    Li N; Zhao Z; Ma H; Liu Y; Nwafor EO; Zhu S; Jia L; Pang X; Han Z; Tian B; Pan H; Liu Z; Pan W
    Mol Pharm; 2022 Nov; 19(11):3831-3845. PubMed ID: 36067066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
    Kim EM; Jeong HJ; Kim SL; Sohn MH; Nah JW; Bom HS; Park IK; Cho CS
    Nucl Med Biol; 2006 May; 33(4):529-34. PubMed ID: 16720245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.
    Zhu XL; Du YZ; Yu RS; Liu P; Shi D; Chen Y; Wang Y; Huang FF
    Int J Mol Sci; 2013 Jul; 14(8):15755-66. PubMed ID: 23899789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
    Mishra D; Jain N; Rajoriya V; Jain AK
    J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress.
    Chen Y; Wu X; Liu C; Zhou Y
    Cell Biochem Funct; 2020 Aug; 38(6):702-709. PubMed ID: 32283563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan-based oral nanoparticles as an efficient platform for kidney-targeted drug delivery in the treatment of renal fibrosis.
    Zhang Q; Li Y; Wang S; Gu D; Zhang C; Xu S; Fang X; Li C; Wu H; Xiong W
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128315. PubMed ID: 38000609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.